Abstract
Type 2 Diabetes Mellitus (T2DM) became a worldwide epidemic with growing proportions, and obesity is an important characteristic of its development. In the therapeutic context, the Roux en Y gastric Bypass (RYGB) has been considered an effective method, capable not only of promoting weight loss, but also supporting T2DM complete resolution. Despite these clinical findings, the glycemic co…